Cost-consequence analysis of aprepitant compared to standard therapy (5-HT 3 + corticosteroids) for the prevention of highly emetogenic chemotherapy-induced nausea and vomit
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.